Neurocognitive Features of Motor Premanifest Individuals With Myotonic Dystrophy Type 1.

Neurol Genet

Department of Psychiatry (E.v.d.P., T.R.K., P.N.), Department of Radiology (V.M.), and Department of Neurology (L.G.), University of Iowa Hospitals and Clinics; and Institute of Molecular, Cell and Systems Biology (S.A.C., D.M.), University of Glasgow, Scotland, United Kingdom.

Published: April 2021

AI Article Synopsis

  • The study aimed to explore brain and functional characteristics related to the premanifest phase of adult-onset myotonic dystrophy type 1 (PreDM1) among different groups, including healthy adults and those with manifest DM1.
  • Results showed that individuals with PreDM1 have intermediate white matter abnormalities, with lower fractional anisotropy compared to healthy controls but better than those with manifest DM1; they also demonstrated reduced finger-tapping performance and sleep issues.
  • These findings suggest notable central nervous system and functional deficits in the early stages of PreDM1, contributing to understanding the disease's progression.

Article Abstract

Objective: The goal of the study was to identify brain and functional features associated with premanifest phases of adult-onset myotonic dystrophy type 1 (i.e., PreDM1).

Methods: This cross-sectional study included 68 healthy adults (mean age = 43.4 years, SD = 12.9), 13 individuals with PreDM1 (mean age: 47.4 years, SD = 16.3), and 37 individuals with manifest DM1 (mean age = 45.2 years, SD = 9.3). The primary outcome measures included fractional anisotropy (FA), motor measures (Muscle Impairment Rating Scale, Grooved Pegboard, Finger-Tapping Test, and grip force), general cognitive abilities (Wechsler Adult Intelligence Scales), sleep quality (Scales for Outcomes in Parkinson's Disease-Sleep), and apathy (Apathy Evaluation Scale).

Results: Individuals with PreDM1 exhibited an intermediate level of white matter FA abnormality, where whole-brain FA was lower relative to healthy controls (difference of the estimated marginal mean [EMM] = 0.02, 95% confidence interval (CI) 0.01-0.03, < 0.001), but the PreDM1 group had significantly higher FA than did individuals with manifest DM1 (EMM = 0.02, 95% CI 0.009-0.03, < 0.001). Individuals with PreDM1 exhibited reduced performance on the finger-tapping task relative to control peers (EMM = 5.70, 95% CI 0.51-11.00, = 0.03), but performance of the PreDM1 group was better than that of the manifest DM1 group (EMM = 5.60, 95% CI 0.11-11.00, = 0.05). Hypersomnolence in PreDM1 was intermediate between controls (EMM = -1.70, 95% CI -3.10-0.35, = 0.01) and manifest DM1 (EMM = -2.10, 95% CI -3.50-0.60, = 0.006).

Conclusions: Our findings highlight key CNS and functional deficits associated with PreDM1, offering insight in early disease course.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075572PMC
http://dx.doi.org/10.1212/NXG.0000000000000577DOI Listing

Publication Analysis

Top Keywords

manifest dm1
16
individuals predm1
12
myotonic dystrophy
8
dystrophy type
8
individuals manifest
8
predm1 exhibited
8
002 95%
8
predm1 group
8
dm1 emm
8
predm1
7

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!